Abstract
Chest CT has been proposed as a surrogate outcome measure in the evaluation of cystic fibrosis lung disease. Quantitative evaluation of chest CT findings requires application of a scoring system to derive numerical values. Several scoring systems are in use. These mostly rely on a subjective judgement of the severity and extent of various features of cystic fibrosis lung disease, including bronchiectasis, bronchial wall thickening, mucous plugging and air-trapping. Scores can subsequently be added to produce a total score. The precision or reproducibility of scoring systems has been assessed but with heterogeneous statistical approaches. Total scores appear to have high levels of reproducibility, but this might mask poorer levels of agreement for individual observations and component scores. It can also be questioned whether total scores are biologically meaningful, as compared to assessments of individual features. Various studies suggest that CT scores give an accurate indicator of the severity of disease, and CT scores might be the best predictors of long-term outcome, but data in this area are limited. CT scores are more sensitive than traditional lung-function indices such as FEV; however the lung clearance index, by multiple breath washout, appears to offer comparable sensitivity to CT. It is not clear whether CT scores are adequately responsive to changes in disease severity in the short to medium term; this is a challenge to the use of CT as a surrogate outcome measure for clinical trials of therapies specific to cystic fibrosis. Cystic fibrosis scoring would benefit from greater levels of standardisation in terms of CT techniques, scoring system, training of observers and measures of reproducibility. Automated approaches to quantifying CT parameters might also offer improved precision. The benefits of chest CT must be weighed against the principal drawback of radiation exposure. The case for more widespread use of chest CT would be strengthened if precision of CT scoring were improved.
Similar content being viewed by others
References
Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: Scoring system with thin-section CT. Radiology 179:783–788
Brody AS, Klein JS, Molina PL et al (2004) High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 145:32–38
Stick SM, Brennan S, Murray C et al (2009) Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 155:623–628
Loeve M, van Hal PT, Robinson P et al (2009) The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax 64:876–882
Westgard JO, Carey RN, Wold S (1974) Criteria for judging precision and accuracy in method development and evaluation. Clin Chem 20:825–833
Ludbrook J (2002) Statistical techniques for comparing measurers and methods of measurement: A critical review. Clin Exp Pharmacol Physiol 29:527–536
Davis SD, Fordham LA, Brody A et al (2007) Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 175:943–950
Owens CM, Aurora P, Stanojevic S et al (2011) London cystic fibrosis collaboration. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 66:481–488
Nasr SZ, Kuhns LR, Brown RW et al (2001) Use of computerized tomography and chest X-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: A preliminary study. Pediatr Pulmonol 31:377–382
Nasr SZ, Gordon D, Sakmar E et al (2006) High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients. Pediatr Pulmonol 41:1129–1137
Brody AS, Kosorok MR, Li Z et al (2006) Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 21:14–21
De Jong PA, Ottink MD, Robben SG et al (2004) Pulmonary disease assessment in cystic fibrosis: Comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 231:434–439
Loeve M, Krestin GP, Rosenfeld M et al (2012) Chest computed tomography: A validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J 42:844–857
De Jong PA, Tiddens HA (2007) Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc 4:338–342
Brenner H, Kliebsch U (1996) Dependence of weighted kappa coefficients on the number of categories. Epidemiology 7:199–202
Gwet KL (2012) Handbook of inter-rater reliability, 3rd edn. Advanced Analytics, Gaithersburg
Long FR, Williams RS, Castile R (2004) Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 144:154–161
De Jong PA, Lindblad A, Rubin L et al (2006) Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 61:80–85
Tepper LA, Utens E, Caudri (2013) Impact of bronchiectasis and trapped air on quality of life and exacerbations in CF. Eur Respir J 42:371–379
Buyse M, Sargent DJ, Grothey A et al (2010) Biomarkers and surrogate end points—the challenge of statistical validation. Nat Rev Clin Oncol 7:309–317
Gupta K, Gupta J, Singh S (2010) Surrogate endpoints: How reliable are they? J Clin Res Best Pract 8:1–6
Katz R (2004) Biomarkers and surrogate markers: An FDA perspective. NeuroRx 1:189–195
Ramsey BW (2007) Use of lung imaging studies as outcome measures for development of new therapies in cystic fibrosis. Proc Am Thorac Soc 4:359–563
De Jong PA, Nakano Y, Lequin MH et al (2004) Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 23:93–97
Demirkazik FB, Ariyürek OM, Ozçelik U et al (2001) High resolution CT in children with cystic fibrosis: Correlation with pulmonary functions and radiographic scores. Eur J Radiol 37:54–59
Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A (2006) Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 63:129–134
Ellemunter H, Fuchs SI, Unsinn KM et al (2010) Sensitivity of lung clearance index and chest computed tomography in early CF lung disease. Respir Med 104:1834–1842
Sanders DB, Li Z, Brody AS, Farrell PM (2011) Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med 184:816–821
Simanovsky N, Cohen-Cymberknoh M, Shoseyov D et al (2013) Differences in the pattern of structural abnormalities on CT in patients with cystic fibrosis and pancreatic sufficiency or insufficiency. Chest 144:208–241
Sly PD, Brennan S, Gangell C et al (2009) Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 180:146–152
Loeve M, Hop WC, de Bruijne M et al (2012) Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 185:1096–1103
Brody AS, Sucharew H, Campbell JD et al (2005) Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 172:1128–1132
Loeve M, Gerbrands K, Hop WC et al (2011) Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest 140:178–185
Byrnes CA, Vidmar S, Cheney JL et al (2013) Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax 68:643–651
Shah RM, Sexauer W, Ostrum BJ et al (1997) High-resolution CT in the acute exacerbation of cystic fibrosis: Evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 169:375–380
Brody AS, Molina PL, Klein JS et al (1999) High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 29:731–735
Horsley AR, Davies JC, Gray RD et al (2013) Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 638:532–539
Moss RB, Rodman D, Spencer LT et al (2004) Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 125:509–521
Robinson TE, Goris ML, Zhu HJ et al (2005) Dornase Alfa reduces air trapping in children with mild cystic fibrosis lung disease: A quantitative analysis. Chest 128:2327–2335
Robinson TE, Leung AN, Northway WH et al (2003) Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 168:588–593
Nasr SZ, Sakmar E, Christodoulou E et al (2010) The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease. Pediatr Pulmonol 45:440–449
Beydon N, Davis SD, Lombardi E et al (2007) An official American thoracic society/European respiratory society statement: Pulmonary function testing in preschool children. Am J Respir Crit Care Med 175:1304–1345
Miller MR, Crapo R, Hankinson J et al (2005) General considerations for lung function testing. Eur Respir J 26:153–161
Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338
Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735
Wanger J, Clausen JL, Coates A et al (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522
Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968
Montaudon M, Berger P, Cangini-Sacher A (2007) Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis. Radiology 242:573–581
Tanaka N, Matsumoto T, Miura G et al (2003) Air trapping at CT: High prevalence in asymptomatic subjects with normal pulmonary function. Radiology 227:776–785
Matsuoka S, Uchiyama K, Shima H et al (2003) Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking. AJR Am J Roentgenol 180:513–518
Mott LS, Park J, Gangell CL et al (2013) Distribution of early structural lung age changes due to cystic fibrosis detected with chest computed tomography. J Pediatr 163:243–248
Kapur N, Masel JP, Watson D et al (2011) Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: Need to redefine bronchial dilatation. Chest 139:1445–1150
Hansell DM, Bankier AA, MacMahon H et al (2008) Fleischner society: Glossary of terms for thoracic imaging. Radiology 246:697–722
Mott LS, Park J, Murray CP et al (2012) Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 67:509–516
Robinson TE (2007) Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 4:310–315
Mumcuoglu EU, Prescott J, Baker BN et al (2009) Image analysis for cystic fibrosis: Automatic lung airway wall and vessel measurement on CT images. Conf Proc IEEE Eng Med Biol Soc 2009:3545–3548
Goris ML, Zhu HJ, Blankenberg F (2003) An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 123:1655–1663
Mott LS, Graniel KG, Park J et al (2013) Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume. Chest 144:1193–1198
Tiddens HA (2006) Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 7:202–208
O’Connell OJ, McWilliams S, McGarrigle A et al (2012) Radiologic imaging in cystic fibrosis: Cumulative effective dose and changing trends over 2 decades. Chest 141:1575–1583
Acknowledgements
A. Bush was supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calder, A.D., Bush, A., Brody, A.S. et al. Scoring of chest CT in children with cystic fibrosis: state of the art. Pediatr Radiol 44, 1496–1506 (2014). https://doi.org/10.1007/s00247-013-2867-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-013-2867-y